Methods for detecting prostate stem cell antigen protein
作者： Owen N. Witte , Robert E. Reiter
DOI:
关键词:
摘要: The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent tumors. also method for detecting (PSCA) protein bone (SEQ ID NO:2), comprising obtaining sample; contacting the sample with an antibody that recognizes binds PSCA protein; and, binding in sample.
lens.org参考文章(124)
Schmidt Lh, Freireich Ej, Skipper He, Gehan Ea, Rall Dp, Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer chemotherapy reports. ,vol. 50, pp. 219- 244 ,(1966)
S Dubinett, J S Economou, J Glaspy, L H Butterfield, W H McBride, S M Kiertscher, J F Arthur, M D Roth, R Lau, L A Bui, A comparison of gene transfer methods in human dendritic cells Cancer Gene Therapy. ,vol. 4, pp. 17- 25 ,(1997)
Shuji Ozaki, Masaaki Kosaka, Shingo Wakatsuki, Masahiro Abe, Yasuo Koishihara, Toshio Matsumoto, Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24 Blood. ,vol. 90, pp. 3179- 3186 ,(1997) , 10.1182/BLOOD.V90.8.3179
Thomas A. Morton, David G. Myszka, Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods in Enzymology. ,vol. 295, pp. 268- 294 ,(1998) , 10.1016/S0076-6879(98)95044-3
Joseph A. Trapani, Vivien R. Sutton, Peter F. Mount, Geoffrey A. Pietersz, Wenjun Li, Ian F.C. McKenzie, Jane Burgess, Chimeric (Mouse/Human) Anti-Colon Cancer Antibody c30.6 Inhibits the Growth of Human Colorectal Cancer Xenografts in scid/scid Mice Cancer Research. ,vol. 54, pp. 6160- 6166 ,(1994)
W. D. W. Heston, W. R. Fair, R. S. Israeli, C. T. Powell, Molecular Cloning of a Complementary DNA Encoding a Prostate-specific Membrane Antigen Cancer Research. ,vol. 53, pp. 227- 230 ,(1993)
D V Morrissey, B A Stone, C A Guindon, H Dorai, G L Davis, J Saltzgaber-Muller, F Toneguzzo, S P Lilly, K W McDonald, B G Sahagan, A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. Journal of Immunology. ,vol. 137, pp. 1066- 1074 ,(1986)
D Brockstedt, E G Engleman, C L Ruegg, L Fong, R Laus, Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer. Journal of Immunology. ,vol. 159, pp. 3113- 3117 ,(1997)
B Shopes, A genetically engineered human IgG mutant with enhanced cytolytic activity. Journal of Immunology. ,vol. 148, pp. 2918- 2922 ,(1992)
M. P. Velders, S. O. Warnaar, C. M. Van Rhijn, S. V. Litvinov, I. H. Briaire, G. J. Fleuren, Immunotherapy with Low and High Affinity Monoclonal Antibodies 17-1A and 323/A3 in a Nude Mouse Xenograft Carcinoma Model Cancer Research. ,vol. 55, pp. 4398- 4403 ,(1995)